These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23879790)

  • 21. Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein.
    Adachi Y; Suzuki H; Sugiyama Y
    Pharm Res; 2001 Dec; 18(12):1660-8. PubMed ID: 11785684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of in vitro P-glycoprotein inhibition assay and its exclusion criteria to assess the risk of drug-drug interaction at the drug discovery stage.
    Sugimoto H; Matsumoto S; Tachibana M; Niwa S; Hirabayashi H; Amano N; Moriwaki T
    J Pharm Sci; 2011 Sep; 100(9):4013-23. PubMed ID: 21678427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R; Naik T; Nigam A; Chatterjee S; Rajanna P; Shen H; Iyer R
    Xenobiotica; 2020 Oct; 50(10):1258-1264. PubMed ID: 32302241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
    Dudley AJ; Brown CD
    Br J Pharmacol; 1996 Mar; 117(6):1139-44. PubMed ID: 8882608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K; Takara K; Tanigawara Y; Aoyama N; Kasuga M; Komada F; Sakaeda T; Okumura K
    Jpn J Cancer Res; 1999 Dec; 90(12):1380-6. PubMed ID: 10665657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
    Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
    Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein.
    Pauli-Magnus C; Rekersbrink S; Klotz U; Fromm MF
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):551-7. PubMed ID: 11770010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel anticancer drug KRN5500 interacts with, but is hardly transported by, human P-glycoprotein.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Jpn J Cancer Res; 2000 Feb; 91(2):248-54. PubMed ID: 10761713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil.
    Higashi H; Watanabe N; Tamura R; Taguchi M
    Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
    Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
    J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of Simplified in Vitro P-Glycoprotein Substrate Assay and in Silico Prediction Models To Evaluate Transport Potential of P-Glycoprotein.
    Ohashi R; Watanabe R; Esaki T; Taniguchi T; Torimoto-Katori N; Watanabe T; Ogasawara Y; Takahashi T; Tsukimoto M; Mizuguchi K
    Mol Pharm; 2019 May; 16(5):1851-1863. PubMed ID: 30933526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alpha-adrenoceptor antagonist doxazosin on MDR1-mediated multidrug resistance and transcellular transport.
    Takara K; Sakaeda T; Kakumoto M; Tanigawara Y; Kobayashi H; Okumura K; Ohnishi N; Yokoyama T
    Oncol Res; 2009; 17(11-12):527-33. PubMed ID: 19806783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide.
    Janga KY; Tatke A; Shukla S; Lamichhane SP; Avula B; Wang X; Jablonski MM; Khan IA; Majumdar S
    J Pharm Sci; 2018 Aug; 107(8):2128-2135. PubMed ID: 29678592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between expression level of P-glycoprotein and daunorubicin transport in LLC-PK1 cells transfected with human MDR1 gene.
    Tanaka K; Hirai M; Tanigawara Y; Ueda K; Takano M; Hori R; Inui K
    Biochem Pharmacol; 1997 Mar; 53(5):741-6. PubMed ID: 9113094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
    Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
    J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymethoxylated flavones in orange juice are inhibitors of P-glycoprotein but not cytochrome P450 3A4.
    Takanaga H; Ohnishi A; Yamada S; Matsuo H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    J Pharmacol Exp Ther; 2000 Apr; 293(1):230-6. PubMed ID: 10734174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
    Shen XM; Cheng J
    DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of carvedilol on MDR1-mediated multidrug resistance: comparison with verapamil.
    Kakumoto M; Sakaeda T; Takara K; Nakamura T; Kita T; Yagami T; Kobayashi H; Okamura N; Okumura K
    Cancer Sci; 2003 Jan; 94(1):81-6. PubMed ID: 12708479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.